299 related articles for article (PubMed ID: 31198170)
1.
Zhang P; Zhuo L; Zou Y; Li G; Peng K
Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
[No Abstract] [Full Text] [Related]
2. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
3. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria.
Chatterjee R; Hoffman M; Cliften P; Seshan S; Liapis H; Jain S
PLoS One; 2013; 8(10):e76360. PubMed ID: 24130771
[TBL] [Abstract][Full Text] [Related]
4. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
5. Kidney Injury by Variants in the
Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
[TBL] [Abstract][Full Text] [Related]
6. Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.
Deltas C; Savva I; Voskarides K; Papazachariou L; Pierides A
Nephron; 2015; 130(4):271-80. PubMed ID: 26201269
[TBL] [Abstract][Full Text] [Related]
7. Atypical Alport syndrome associated with a novel COL4A5 mutation.
Höpker K; Liebau MC; Friederichsohn C; Waldherr R; Benzing T
Clin Nephrol; 2009 Mar; 71(3):321-5. PubMed ID: 19281745
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
Savige J; Harraka P
Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
[TBL] [Abstract][Full Text] [Related]
9. Alport's syndrome with focal segmental glomerulosclerosis lesion - Pattern to recognize.
Alsahli AA; Alshahwan SI; Alotaibi AO; Alsaad KO; Aloudah N; Farooqui M; Al Sayyari AA
Saudi J Kidney Dis Transpl; 2018; 29(1):167-172. PubMed ID: 29456224
[TBL] [Abstract][Full Text] [Related]
10. Refractory focal segmental glomerulosclerosis caused by Alport syndrome detected by genetic testing after three decades.
Oda Y; Sawa N; Nozu K; Ubara Y
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35288428
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the ocular features in Pierson and Alport syndrome: a case report and literature review.
Gooley K; Williams P; Mack H; Zhu V; Langsford D; Pianta T; Barit D; Mahmood K; Savige J
Ophthalmic Genet; 2023 Oct; 44(5):417-422. PubMed ID: 37537573
[TBL] [Abstract][Full Text] [Related]
13. [Study of a family affected with focal segmental glomerulosclerosis due to mutation of COL4A5 gene].
Zhang J; Yang J; Hu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):373-376. PubMed ID: 28604958
[TBL] [Abstract][Full Text] [Related]
14. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.
Malone AF; Phelan PJ; Hall G; Cetincelik U; Homstad A; Alonso AS; Jiang R; Lindsey TB; Wu G; Sparks MA; Smith SR; Webb NJ; Kalra PA; Adeyemo AA; Shaw AS; Conlon PJ; Jennette JC; Howell DN; Winn MP; Gbadegesin RA
Kidney Int; 2014 Dec; 86(6):1253-9. PubMed ID: 25229338
[TBL] [Abstract][Full Text] [Related]
15. A novel heterozygous variant of the COL4A4 gene in a Chinese family with hematuria and proteinuria leads to focal segmental glomerulosclerosis and chronic kidney disease.
Fan LL; Liu L; Luo FM; Du R; Wang CY; Dong Y; Liu JS
Mol Genet Genomic Med; 2020 Dec; 8(12):e1545. PubMed ID: 33159707
[TBL] [Abstract][Full Text] [Related]
16. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic heterogeneity in females with X-linked Alport syndrome.
Allred SC; Weck KE; Gasim A; Mottl AK
Clin Nephrol; 2015 Nov; 84(5):296-300. PubMed ID: 26249550
[TBL] [Abstract][Full Text] [Related]
18. Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.
Li Y; Wang Y; He Q; Dang X; Cao Y; Wu X; Mo S; He X; Yi Z
Mol Med Rep; 2018 Jan; 17(1):1513-1526. PubMed ID: 29138824
[TBL] [Abstract][Full Text] [Related]
19. Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant.
Gibson J; Gilbert RD; Bunyan DJ; Angus EM; Fowler DJ; Ennis S
Genet Res (Camb); 2013 Dec; 95(6):165-73. PubMed ID: 24472419
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome.
Li Z; Zhu P; Huang H; Pan Y; Han P; Cui H; Kang Z; Xun M; Zhang Y; Liu S; Wang J; Wu J
Sci China Life Sci; 2019 Dec; 62(12):1572-1579. PubMed ID: 31209800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
